Adenosine A2a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress

Acta Physiologica

Volumn 214, Issue 3, 2015, Pages 311-318

  Persson, P ^a   Friederich Persson, M ^a   Fasching, A ^a   Hansell, P ^a   Inagi, R ^b   Palm, F ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TOKYO   (Japan)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

CGS21680; Diabetes mellitus; Diabetic nephropathy; Kidney; Macrophages; Tumour necrosis factor alpha

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; INTERLEUKIN 10; ADENOSINE; CYTOKINE; IMMUNOLOGIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETOGENESIS; GLOMERULUS FILTRATION RATE; IMMUNOCOMPETENT CELL; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MASS; MACROPHAGE; MALE; MICTURITION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TENSION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENAL PROTECTION; STIMULATION; TREATMENT DURATION; URINARY EXCRETION; ANIMAL; IMMUNOLOGY; INFLAMMATION; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; CYTOKINES; DIABETIC NEPHROPATHIES; IMMUNOLOGIC FACTORS; INFLAMMATION; MALE; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A;

EID: 84931264834     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12511     Document Type: Article

References (35)

1. Awad, A.S., Huang, L., Ye, H., Duong, E.T., Bolton, W.K., Linden, J. & Okusa, M.D. 2006. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol 290, F828-F837.
2. Basile, D.P., Donohoe, D.L., Roethe, K. & Mattson, D.L. 2003. Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284, F338-F348.
3. Bjorck, S., Mulec, H., Johnsen, S.A., Norden, G. & Aurell, M. 1992. Renal protective effect of enalapril in diabetic nephropathy. BMJ 304, 339-343.
4. Bohle, A., Wehrmann, M., Bogenschutz, O., Batz, C., Muller, C.A. & Muller, G.A. 1991. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 187, 251-259.
5. Collins, A.J., Foley, R.N., Chavers, B., Gilbertson, D., Herzog, C., Ishani, A., Johansen, K., Kasiske, B.L., Kutner, N., Liu, J. et al. 2014. US renal data system 2013 annual data report. Am J Kidney Dis 63, A7.
6. El-Awady, M.S., Rajamani, U., Teng, B., Tilley, S.L. & Mustafa, S.J. 2013. Evidence for the involvement of NADPH oxidase in adenosine receptors-mediated control of coronary flow using A and A knockout mice. Physiol Rep 1, e00070.
7. Friederich-Persson, M., Thorn, E., Hansell, P., Nangaku, M., Levin, M. & Palm, F. 2013. Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress. Hypertension 62, 914-919.
8. Gessi, S., Varani, K., Merighi, S., Ongini, E. & Borea, P.A. 2000. A(2A) adenosine receptors in human peripheral blood cells. Br J Pharmacol 129, 2-11.
9. Gill, A., Wortham, K., Costa, D., Davis, W., Ticho, B. & Whalley, E. 2009. Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats. Am J Nephrol 30, 521-526.
10. Gupta, S., Gambhir, J.K., Kalra, O., Gautam, A., Shukla, K., Mehndiratta, M., Agarwal, S. & Shukla, R. 2013. Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population. J Diabetes Complications 27, 548-552.
11. Kinsey, G.R., Huang, L., Jaworska, K., Khutsishvili, K., Becker, D.A., Ye, H., Lobo, P.I. & Okusa, M.D. 2012. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol 23, 1528-1537.
12. Kinsey, G.R., Sharma, R., Huang, L., Li, L., Vergis, A.L., Ye, H., Ju, S.T. & Okusa, M.D. 2009. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20, 1744-1753.
13. Koscso, B., Csoka, B., Kokai, E., Nemeth, Z.H., Pacher, P., Virag, L., Leibovich, S.J. & Hasko, G. 2013. Adenosine augments IL-10-induced STAT3 signaling in M2c macrophages. J Leukoc Biol 94, 1309-1315.
14. Kreckler, L.M., Wan, T.C., Ge, Z.D. & Auchampach, J.A. 2006. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 317, 172-180.
15. Kumagai, T., Nangaku, M., Kojima, I., Nagai, R., Ingelfinger, J.R., Miyata, T., Fujita, T. & Inagi, R. 2009. Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 296, F912-F921.
16. Lewis, A., Steadman, R., Manley, P., Craig, K., de la Motte, C., Hascall, V. & Phillips, A.O. 2008. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Histol Histopathol 23, 731-739.
17. Lewis, E.J., Hunsicker, L.G., Bain, R.P. & Rohde, R.D. 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329, 1456-1462.
18. Matejka, J., Varvarovsky, I., Vojtisek, P., Herman, A., Rozsival, V., Borkova, V. & Kvasnicka, J. 2010. Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease. Heart Vessels 25, 536-542.
19. Mathot, R.A., Cleton, A., Soudijn, W., IJzerman, A.P. & Danhof, M. 1995. Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats. Br J Pharmacol 114, 761-768.
20. Mimura, I. & Nangaku, M. 2010. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 6, 667-678.
21. Mora, C. & Navarro, J.F. 2006. Inflammation and diabetic nephropathy. Curr Diab Rep 6, 463-468.
22. Motonishi, S., Nangaku, M., Wada, T., Ishimoto, Y., Ohse, T., Matsusaka, T., Kubota, N., Shimizu, A., Kadowaki, T., Tobe, K. & Inagi, R. 2014. Sirtuin1 maintains actin cytoskeleton by deacetylation of cortactin in injured podocytes. J Am Soc Nephrol [Epub ahead of print].
23. Nagase, R., Kajitani, N., Shikata, K., Ogawa, D., Kodera, R., Okada, S., Kido, Y. & Makino, H. 2012. Phenotypic change of macrophages in the progression of diabetic nephropathy; sialoadhesin-positive activated macrophages are increased in diabetic kidney. Clin Exp Nephrol 16, 739-748.
24. Nordquist, L., Friederich-Persson, M., Fasching, A., Liss, P., Shoji, K., Nangaku, M., Hansell, P. & Palm, F. 2015. Activation of hypoxia-inducible factors prevents diabetic nephropathy. J Am Soc Nephrol 26, 328-338.
25. Omote, K., Gohda, T., Murakoshi, M., Sasaki, Y., Kazuno, S., Fujimura, T., Ishizaka, M., Sonoda, Y. & Tomino, Y. 2014. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Am J Physiol Renal Physiol 306, F1335-F1347.
26. Palm, F., Cederberg, J., Hansell, P., Liss, P. & Carlsson, P.O. 2003. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46, 1153-1160.
27. Parving, H.H., Hommel, E., Jensen, B.R. & Hansen, H.P. 2001. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int 60, 228-234.
28. Persson, M.F., Franzen, S., Catrina, S.B., Dallner, G., Hansell, P., Brismar, K. & Palm, F. 2012a. Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 55, 1535-1543.
29. Persson, P., Hansell, P. & Palm, F. 2012b. NADPH oxidase inhibition reduces tubular sodium transport and improves kidney oxygenation in diabetes. Am J Physiol Regul Integr Comp Physiol 302, R1443-R1449.
30. Persson, P., Hansell, P. & Palm, F. 2015. Reduced adenosine A2a receptor-mediated efferent arteriolar vasodilation contributes to diabetes-induced glomerular hyperfiltration. Kidney Int 87, 109-115.
31. Ribe, D., Sawbridge, D., Thakur, S., Hussey, M., Ledent, C., Kitchen, I., Hourani, S. & Li, J.M. 2008. Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity. Free Radic Biol Med 44, 1433-1442.
32. Schmidt, K.N., Amstad, P., Cerutti, P. & Baeuerle, P.A. 1995. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol 2, 13-22.
33. Stenvinkel, P., Wanner, C., Metzger, T., Heimburger, O., Mallamaci, F., Tripepi, G., Malatino, L. & Zoccali, C. 2002. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 62, 1791-1798.
34. Wang, Z., Wei, M., Wang, M., Chen, L., Liu, H., Ren, Y., Shi, K. & Jiang, H. 2014. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice. Inflammation 37, 2020-2029.
35. Xiao, H., Shen, H.Y., Liu, W., Xiong, R.P., Li, P., Meng, G., Yang, N., Chen, X., Si, L.Y. & Zhou, Y.G. 2013. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS ONE 8, e60173.